Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
1(8%)
Results Posted
86%(6 trials)

Phase Distribution

Ph phase_3
4
33%
Ph phase_4
8
67%

Phase Distribution

0

Early Stage

0

Mid Stage

12

Late Stage

Phase Distribution12 total trials
Phase 3Large-scale testing
4(33.3%)
Phase 4Post-market surveillance
8(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

12

all time

Status Distribution
Active(2)
Completed(7)
Other(3)

Detailed Status

Completed7
unknown3
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 34 (33.3%)
Phase 48 (66.7%)

Trials by Status

recruiting18%
completed758%
not_yet_recruiting18%
unknown325%

Recent Activity

Clinical Trials (12)

Showing 12 of 12 trials
NCT07112144Phase 3

Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial

Recruiting
NCT06920069Phase 4

Study of Concomitant Administration of the sIPV and DTaP or MMR

Not Yet Recruiting
NCT03165981Phase 4

Fever After Simultaneous Versus Sequential Vaccination in Young Children

Completed
NCT03530124Phase 4

Apnea in Hospitalized Preterm Infants Following the Administration of Routine Childhood Vaccines

Completed
NCT04054882Phase 4

Evaluation of the Safety and Immunogenicity of Simultaneously Administration of sIPV and DTaP

Completed
NCT04638985Phase 4

Evaluation of Immunogenicity and Safety of Combined Immunization of sIPV, DTaP and MMR

Unknown
NCT04636827Phase 4

Evaluation of Safety and Immunogenicity of Combined Immunization of sIPV, DTaP and HepA

Unknown
NCT04053010Phase 4

Clinic Trial to Evaluate the Safety and Immunogenicity of Combined Immunization of sIPV and DTaP

Unknown
NCT01200368Phase 3

Trial Evaluating a 13-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants

Completed
NCT02062385Phase 3

Efficacy, Safety, and Immunogenicity of V260 in Healthy Chinese Infants (V260-024)

Completed
NCT00474526Phase 3

A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants

Completed
NCT01250756Phase 4

A Trial Evaluating a 7-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants.

Completed

All 12 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
12